These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
159 related items for PubMed ID: 2458511
21. Effect of naloxone on morphine-induced changes in striatal dopamine metabolism and glutamate, ascorbic acid and uric acid release in freely moving rats. Enrico P, Mura MA, Esposito G, Serra P, Migheli R, De Natale G, Desole MS, Miele M, Miele E. Brain Res; 1998 Jun 22; 797(1):94-102. PubMed ID: 9630540 [Abstract] [Full Text] [Related]
22. 6-Hydroxydopamine and 5,7-dihydroxytryptamine selectively reduce dopamine and 5-hydroxytryptamine metabolites in cerebroventricular perfusates of rats. Nielsen JA, Moore KE. Pharmacol Biochem Behav; 1983 Nov 22; 19(5):905-7. PubMed ID: 6417682 [Abstract] [Full Text] [Related]
23. Acute effects of intranigral application of MPP+ on nigral and bilateral striatal release of dopamine simultaneously recorded by microdialysis. Santiago M, Rollema H, de Vries JB, Westerink BH. Brain Res; 1991 Jan 11; 538(2):226-30. PubMed ID: 1707325 [Abstract] [Full Text] [Related]
24. Lesion-induced reductions in trace amine accumulation: dependence on MAO inhibitor pretreatment. Nguyen TV, Juorio AV, Greenshaw AJ. Brain Res Bull; 1989 Feb 11; 22(2):197-200. PubMed ID: 2495844 [Abstract] [Full Text] [Related]
25. Postmortem changes in the levels of monoamine metabolites in human cerebrospinal fluid. Endo T, Hara S, Kuriiwa F, Kano S. Forensic Sci Int; 1990 Jan 11; 44(1):61-8. PubMed ID: 1689267 [Abstract] [Full Text] [Related]
26. Cerebrospinal fluid probenecid studies: a reinterpretation. Cowdry RW, Ebert MH, van Kammen DP, Post RM, Goodwin FK. Biol Psychiatry; 1983 Nov 11; 18(11):1287-99. PubMed ID: 6197100 [Abstract] [Full Text] [Related]
27. Study of dopamine turnover by monitoring the decline of dopamine metabolites in rat CSF after alpha-methyl-p-tyrosine. Mignot E, Laude D. J Neurochem; 1985 Nov 11; 45(5):1527-33. PubMed ID: 2864397 [Abstract] [Full Text] [Related]
28. Cholinergic stimulation of substantia nigra: abolition of carbachol-induced eating by unilateral 6-hydroxydopamine lesion of nigrostriatal dopamine neurones. Parker GC, Rugg EL, Winn P. Exp Brain Res; 1991 Nov 11; 87(3):597-603. PubMed ID: 1723691 [Abstract] [Full Text] [Related]
30. [Concentrations of monoamines and monoamine metabolites in cerebrospinal fluid determined by high-performance liquid chromatography with electrochemical detection]. Yoshino K. No To Shinkei; 1982 Nov 11; 34(11):1099-106. PubMed ID: 6186264 [Abstract] [Full Text] [Related]
31. Repetitive measurement of monoamine metabolite levels in cerebrospinal fluid of conscious rats: effects of reserpine and haloperidol. Scheinin H, Scheinin M. Eur J Pharmacol; 1985 Jul 31; 113(3):345-51. PubMed ID: 2412847 [Abstract] [Full Text] [Related]
32. Enhancement of brain dopamine metabolism by tyrosine during immobilisation: an in vivo study using repeated cerebrospinal fluid sampling in conscious rats. Marcou M, Kennett GA, Curzon G. J Neurochem; 1987 Apr 31; 48(4):1245-51. PubMed ID: 2434619 [Abstract] [Full Text] [Related]
33. Assessment of cerebrospinal fluid levels of dopamine metabolites by gas chromatography. Watson E, Wilk S. Psychopharmacologia; 1975 Apr 30; 42(1):57-6. PubMed ID: 1153623 [Abstract] [Full Text] [Related]
34. Early increase in dopamine release in the ipsilateral striatum after unilateral intranigral administration of lactacystin produces spontaneous contralateral rotations in rats. Konieczny J, Lenda T, Czarnecka A. Neuroscience; 2016 Jun 02; 324():92-106. PubMed ID: 26964686 [Abstract] [Full Text] [Related]
35. Electroconvulsive shock produces large increases in interstitial concentrations of dopamine in the rat striatum: an in vivo microdialysis study. Nomikos GG, Zis AP, Damsma G, Fibiger HC. Neuropsychopharmacology; 1991 Jan 02; 4(1):65-9. PubMed ID: 1706182 [Abstract] [Full Text] [Related]
36. Drug-induced circling preference in rats. Correlation with monoamine levels. Ali SF, Kordsmeier KJ, Gough B. Mol Neurobiol; 1995 Jan 02; 11(1-3):145-54. PubMed ID: 8561958 [Abstract] [Full Text] [Related]
37. Increased dopamine release from striata of rats after unilateral nigrostriatal bundle damage. Zhang WQ, Tilson HA, Nanry KP, Hudson PM, Hong JS, Stachowiak MK. Brain Res; 1988 Oct 04; 461(2):335-42. PubMed ID: 3141002 [Abstract] [Full Text] [Related]
38. Monoamine metabolites in normal human cerebrospinal fluid and in degenerative diseases of the central nervous system. González-Quevedo A, García JC, Fernández R, Fernández Cartaya L. Bol Estud Med Biol; 1993 Oct 04; 41(1-4):13-9. PubMed ID: 7521168 [Abstract] [Full Text] [Related]
39. CSF monamine metabolites in movement disorders and normal aging. Stahl SM, Faull KF, Barchas JD, Berger PA. Arch Neurol; 1985 Feb 04; 42(2):166-9. PubMed ID: 2579626 [Abstract] [Full Text] [Related]
40. Efficacy of brain-derived neurotrophic factor and neurotrophin-3 on neurochemical and behavioral deficits associated with partial nigrostriatal dopamine lesions. Altar CA, Boylan CB, Fritsche M, Jones BE, Jackson C, Wiegand SJ, Lindsay RM, Hyman C. J Neurochem; 1994 Sep 04; 63(3):1021-32. PubMed ID: 7519657 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]